Medical/Pharmaceuticals

China's First NDA for a KRAS G12C Inhibitor: NMPA Accepts New Drug Application for GFH925 and Grants GFH925 with Priority Review Designation

SHANGHAI, Nov. 24, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) ofChina has accepted the...

2023-11-24 19:00 2239

Neurophet to showcase brain image analysis technology at RSNA 2023

- Introducing Alzheimer's disease related brain image analysis technology including Neurophet AQUA and Neurophet SCALE PET - Plans to launch analysis technology for infant brain image and cerebrovascular disease SEOUL, South Korea, Nov. 23, 2023 /PRNewswire/ -- Neurophet, an artificial intellig...

2023-11-23 22:00 2043

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

* Study reveals a promising avenue for addressing Idiopathic Systemic Capillary Leak Syndrome (ISCLS, a.k.a. Clarkson Disease) and vessel-related rare disease indications * Unique Tie2-activating antibody program, PMC-403, demonstrates efficacy in improving survival and reducing vascular leak...

2023-11-23 10:31 1636

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with that of radiologists in detecting breast cancer SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...

2023-11-22 22:07 2082

United Imaging Intelligence to Unveil Cutting-edge AI Technology at RSNA

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- United Imaging Intelligence (UII), a pioneering subsidiary of United Imaging Group known for its innovative artificial intelligence (AI) applications in healthcare, is set to showcase its latest medical AI advancements at the upcoming Radiological Society o...

2023-11-22 22:00 1761

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

* By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture to final UF/DF pool at pilot scale * This end-to-end continuous bioprocess, which is in place for WuXi Biologics global manufacturing network, is...

2023-11-22 13:21 3600

Baird Medical Attains FDA Clearance to Market Its Microwave Ablation System in the United States

FRISCO, Texas, Nov. 21, 2023 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Betters (Suzhou) Medical Co., Ltd, has received clearance from the ...

2023-11-22 06:00 1668

United Imaging Showcases Pioneering Advances and Reinforces U.S. Growth at RSNA 2023

HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023. This includes another series of global firsts and pioneering medical...

2023-11-21 14:57 1435

ST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop

SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the Korea-CEPI R&D Workshop in World Bio Summit 2023, organized by Korea Health Industry Development...

2023-11-21 12:00 1400

Concord Medical Schedules 2023 Annual Meeting of Shareholders

BEIJING, Nov. 20, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensi...

2023-11-21 05:00 1611

Preserving Tradition in the Digital Age: A Historic Collaboration for Digitising Bhutan's Medicinal Plants and Herbs

NEW YORK and SINGAPORE, Nov. 20, 2023 /PRNewswire/ -- In a landmark move, four eminent organisations have united under a Memorandum of Understanding (MOU) signed on17 November 2023. This alliance aims to digitise and certify Bhutan's treasured Sowa-Rigpa, the ancient Traditional Medicines know...

2023-11-20 22:00 1733

CARsgen Announces Formation of its Clinical Advisory Board

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the formation of its Clinical Advisory Board. This highly regarded pa...

2023-11-20 21:50 2727

Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging

SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell therapy, and accelerate the application of NK cells in ca...

2023-11-20 20:00 1220

First Subject Enrolled in Phase 1 Study of MRX-5

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as "MicuRx") announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...

2023-11-20 18:34 1457

GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023

Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...

2023-11-20 14:39 1432

Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.

SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...

2023-11-18 08:00 3082

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologie...

2023-11-17 22:21 3765

Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform

YANGZHOU, China, Nov. 17, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today the upcoming la...

2023-11-17 21:00 1439

Taiwan Lubricate for academic research and health products development

TAICHUNG, Nov. 17, 2023 /PRNewswire/ -- Based in Taiwan, T-BAL is the leading service provider in measurements of lipids and metabolites for both academics and industry. In the collaboration with Lipotype GmbH,Germany (the world leader in lipidomics profiling service), T-BAL has developed advance...

2023-11-17 20:00 1241

Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference

Using single cell multi-omics analysis to predict treatment outcome, develop disease prognostics and track patient responses to CAR T therapies COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies , a company at the forefront of developing and commerc...

2023-11-17 17:58 1409
1 ... 49505152535455 ... 214

Week's Top Stories